Pharmacokinetics of Posaconazole Given as a Single Intravenous Dose to Obese Subjects: Dosing Obese With Noxafil® Under a Trial (DONUT)
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2018
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Chagas disease; Mycoses; Oropharyngeal candidiasis
- Focus Pharmacokinetics
- Acronyms DONUT
- 20 Sep 2018 Status changed from recruiting to completed.
- 14 Nov 2017 Status changed from not yet recruiting to recruiting.
- 16 Aug 2017 New trial record